Showing 561 - 580 results of 122,765 for search '(( 2 d decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.88s Refine Results
  1. 561

    CXCL12 expression results in decreased proliferation of PDAC cells. by Ishan Roy (530438)

    Published 2014
    “…(C–D) Propidium Iodide cell cycle analysis revealed a decrease in percentage of cells in the G<sub>2</sub> phase in CXCL12-expressing cells compared to GFP controls. (*), (**), and (***) denote <i>P</i>≤0.05, <i>P</i>≤0.01, and <i>P</i>≤0.001 respectively in comparison to control cells (GFP). …”
  2. 562
  3. 563
  4. 564
  5. 565

    SPL decreases diabetes-induced oxidative stress in GL and PT. by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…SPL treatment prevents diabetes-induced increment in O<sub>2</sub><sup>●―</sup> production (A) by using nicotinamide adenine dinucleotide phosphate (NADPH) as substrate and, diphenyleneiodonium (DPI) as inhibitor, lipid peroxidation (B) and protein carbonylation (C) and decreased GSH content (D) in GL (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s003" target="_blank">S3 Fig</a>). …”
  6. 566
  7. 567
  8. 568

    Topical application of ATX inhibitor (S32826) decreases IOP in rabbits. by Padma Iyer (141117)

    Published 2012
    “…Further, IOP in the drug treated eyes was significantly reduced as compared to IOP in the control eyes based on the Wilcoxon Rank Sum test of differences in median's (n = 9). C and D. Effects of 5 and 2 mM S32826 on IOP with a daily (single morning dose, 35 µl×2; n = 4) dose of drug application, respectively. …”
  9. 569
  10. 570
  11. 571
  12. 572
  13. 573
  14. 574

    Decreased TORC1 activates HPK-1 to extend longevity. by Ritika Das (4514968)

    Published 2017
    “…<p>(A-D) Decreased TORC1 induces neuronal expression of HPK-1. …”
  15. 575
  16. 576
  17. 577
  18. 578
  19. 579
  20. 580